Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
A Piccioni, F Rosa, F Manca, G Pignataro… - International Journal of …, 2022 - mdpi.com
Our digestive system, particularly our intestines, harbors a vast amount of microorganisms,
whose genetic makeup is referred to as the microbiome. Clostridium difficile is a spore …
whose genetic makeup is referred to as the microbiome. Clostridium difficile is a spore …
[HTML][HTML] Health Benefits of Prebiotics, Probiotics, Synbiotics, and Postbiotics
N Al-Habsi, M Al-Khalili, SA Haque, M Elias, NA Olqi… - Nutrients, 2024 - mdpi.com
The trillions of microbes that constitute the human gut microbiome play a crucial role in
digestive health, immune response regulation, and psychological wellness. Maintaining gut …
digestive health, immune response regulation, and psychological wellness. Maintaining gut …
A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections
Clostridial infections, known for their severity and rapid progression, present significant
challenges in both clinical and veterinary fields. These bacteria, which can survive without …
challenges in both clinical and veterinary fields. These bacteria, which can survive without …
Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated …
I Efremova, R Maslennikov, M Zharkova… - Journal of Clinical …, 2024 - mdpi.com
(1) Background: The aim was to evaluate the effectiveness of the probiotic containing
Saccharomyces boulardii in the treatment of small intestinal bacterial overgrowth (SIBO) in …
Saccharomyces boulardii in the treatment of small intestinal bacterial overgrowth (SIBO) in …
Evolving advances in the cosmetic use of probiotics and postbiotics: health, regulatory and marketing aspects
Ongoing development in cosmetics is increasingly making use of probiotics, which are
defined as “live microorganisms with health-enhancing properties mediated through …
defined as “live microorganisms with health-enhancing properties mediated through …
Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile
Clostridioides difficile, the causative agent of antibiotic-associated diarrhea and
pseudomembranous colitis, has emerged as a major enteric pathogen in recent years …
pseudomembranous colitis, has emerged as a major enteric pathogen in recent years …
[HTML][HTML] Gut microbiota-centered risk factors and altered immunometabolism in the pathogenesis and prophylaxis of Clostridium difficile infection
Aim Clostridium difficile (C. diff.) infection (CDI) is the major contributor of nosocomial
infection globally. The current review aims to provide a comprehensive understanding of the …
infection globally. The current review aims to provide a comprehensive understanding of the …
Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment
D Taghaddos, Z Saqib, X Bai, P Bercik… - Digestive and Liver …, 2024 - Elsevier
Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI)
develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI …
develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI …
Intestinal microbiota: The driving force behind advances in cancer immunotherapy
Z Dai, J Fu, X Peng, D Tang, J Song - Cancers, 2022 - mdpi.com
Simple Summary Despite the great achievements of cancer immunotherapy in a variety of
tumors, tumor heterogeneity and drug resistance still plague patients and clinical …
tumors, tumor heterogeneity and drug resistance still plague patients and clinical …
Screening novel antiviral compounds to treat Clostridioides difficile infections
BJ Stolz, AA Abouelkhair, MN Seleem - PloS one, 2024 - journals.plos.org
Clostridioides difficile is a major cause of nosocomial infections, often associated with
individuals who have gut dysbiosis from previous antibiotic therapies. C. difficile infections …
individuals who have gut dysbiosis from previous antibiotic therapies. C. difficile infections …